Eastman Chemical
EMN | NYSE
$65.41
-$0.28 (-0.43%)
Sep 21, 2026, 12:49 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 8.75B | 9.38B | 9.2B | 10.54B | 10.48B | 8.46B |
Cost of Revenue | 6.91B | 7.09B | 7.14B | 8.48B | 7.97B | 6.46B |
Gross Profit | 1.84B | 2.29B | 2.06B | 2.06B | 2.52B | 2.01B |
Operating Income | 931M | 1.38B | 1.1B | 1.08B | 1.47B | 1.13B |
Interest Income | n/a | 16M | 10M | 6M | 3M | 4M |
Pretax Income | 568M | 1.08B | 1.09B | 977M | 1.08B | 530M |
Net Income | 474M | 905M | 894M | 793M | 857M | 478M |
Selling & General & Admin | 658M | 664M | 727M | 708M | 795M | 654M |
Research & Development | 255M | 250M | 239M | 264M | 254M | 226M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 913M | 914M | 966M | 972M | 1.05B | 880M |
Interest Expense | 208M | 216M | 225M | 188M | 192M | 205M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.82B | 8.01B | 8.1B | 9.45B | 9.01B | 7.34B |
Income Tax Expense | 93M | 170M | 191M | 181M | 215M | 41M |
Shares Outstanding (Basic) | 114.7M | 116.7M | 118.6M | 123.5M | 134.9M | 135.5M |
Shares Outstanding (Diluted) | 115.6M | 117.9M | 119.4M | 124.9M | 137.1M | 136.5M |
EPS (Basic) | 4.13 | 7.75 | 7.54 | 6.42 | 6.35 | 3.53 |
EPS (Diluted) | 4.10 | 7.67 | 7.49 | 6.35 | 6.25 | 3.50 |
EBITDA | 1.29B | 1.8B | 1.81B | 1.64B | 1.81B | 1.31B |
EBIT | 776M | 1.29B | 1.31B | 1.16B | 1.27B | 735M |
Depreciation & Amortization | 513M | 509M | 498M | 477M | 538M | 574M |
Add to Watchlist
Select watchlists to add or remove EMN